Amalgamated Bank’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26K | Hold |
7,197
| – | – | ﹤0.01% | 2014 |
|
|
2025
Q1 | $14K | Hold |
7,197
| – | – | ﹤0.01% | 2198 |
|
|
2024
Q4 | $14K | Hold |
7,197
| – | – | ﹤0.01% | 2258 |
|
|
2024
Q3 | $10K | Hold |
7,197
| – | – | ﹤0.01% | 2432 |
|
|
2024
Q2 | $7K | Buy |
+7,197
| New | +$7K | ﹤0.01% | 2591 |
|
|
2022
Q2 | – | Sell |
-24,241
| Closed | -$17K | – | 3028 |
|
|
2022
Q1 | $17K | Sell |
24,241
-1,832
| -7% | -$1.29K | ﹤0.01% | 2843 |
|
|
2021
Q4 | $59K | Buy |
26,073
+1,040
| +4% | +$2.35K | ﹤0.01% | 2104 |
|
|
2021
Q3 | $72K | Sell |
25,033
-732
| -3% | -$2.11K | ﹤0.01% | 2108 |
|
|
2021
Q2 | $98K | Buy |
25,765
+3,381
| +15% | +$12.9K | ﹤0.01% | 2121 |
|
|
2021
Q1 | $76K | Hold |
22,384
| – | – | ﹤0.01% | 1564 |
|
|
2020
Q4 | $63K | Buy |
22,384
+118
| +0.5% | +$332 | ﹤0.01% | 1553 |
|
|
2020
Q3 | $56K | Buy |
22,266
+1,446
| +7% | +$3.64K | ﹤0.01% | 1449 |
|
|
2020
Q2 | $283K | Buy |
20,820
+2,394
| +13% | +$32.5K | 0.01% | 1135 |
|
|
2020
Q1 | $140K | Sell |
18,426
-780
| -4% | -$5.93K | ﹤0.01% | 1444 |
|
|
2019
Q4 | $121K | Buy |
19,206
+1,703
| +10% | +$10.7K | ﹤0.01% | 1713 |
|
|
2019
Q3 | $69K | Sell |
17,503
-210
| -1% | -$828 | ﹤0.01% | 1683 |
|
|
2019
Q2 | $86K | Buy |
17,713
+4,336
| +32% | +$21.1K | ﹤0.01% | 1705 |
|
|
2019
Q1 | $110K | Buy |
13,377
+438
| +3% | +$3.6K | ﹤0.01% | 1596 |
|
|
2018
Q4 | $72K | Buy |
+12,939
| New | +$72K | ﹤0.01% | 1544 |
|